News about Market

Trialt Partners with Viedoc to Streamline Clinical Trials and Enhance Data-Driven Decision-Making

The strategic collaboration between Trialt Partners and Viedoc integrates biometrics expertise with cloud-based eClinical technology to accelerate timelines and improve data quality across global studies.

Market | 07/04/2026 | By News Bureau

Neurocrine to Acquire Soleno Therapeutics

Neurocrine to acquire Soleno Therapeutics, adding US FDA-approved VYKAT XR for Prader-Willi Syndrome and strengthening its rare disease and endocrinology portfolio.

Market | 07/04/2026 | By News Bureau

Biocytogen and Sihuan Pharmaceutical Partner to Advance Next-Gen Antibody Therapies

The strategic collaboration between Bioctogen and Sihuan Pharmaceutical combines antibody discovery platforms and manufacturing expertise to accelerate development of innovative treatments, including weight loss therapies.

Market | 06/04/2026 | By News Bureau

Glenmark Takes Charge of RYALTRIS Commercialisation in US

Glenmark will handle end-to-end commercialisation and distribution of RYALTRIS nasal spray in the US, strengthening its respiratory portfolio presence.

Market | 06/04/2026 | By News Bureau |  298

Symbiosis Expands QC Capabilities with New Stability Chamber to Support Global Drug Supply

Symbiosis enhances its quality control lab with a new stability chamber, enabling comprehensive climate-based testing for global distribution of injectable drug products.

Market | 06/04/2026 | By News Bureau |  151

Syneron Bio Raises USD 150 Million in Series B Funding

Syneron Bio raises USD 150 million in Series B to advance its Synova macrocyclic peptide platform and accelerate pipeline development towards clinical stages.

Market | 06/04/2026 | By News Bureau

TechBio Startup Generare Raises 20 Million Euros to Unlock Novel Drug Discovery Data

Generare, a techbio company focused on generating novel molecular data for drug discovery, has raised 20 million euros in a Series A funding round co-led by Alven and Daphni, with participation from existing investors including Galion.exe, Teampact Ventures and VIVES Partners.

Market | 04/04/2026 | By Darshana |  162

Aspect Biosystems Secures USD 280 Million Canada Partnership for Bioengineered Cell Therapies

Aspect Biosystems secures USD 280 Million partnership with Canada to advance bioengineered cell therapies, accelerating clinical development and expanding biomanufacturing capabilities.

Market | 04/04/2026 | By News Bureau

MHRA Approves Bayer's Sevabertinib for HER2-Mutated Advanced Lung Cancer

Sevabertinib, a targeted therapy for HER2-mutated lung cancer, has been approved by the UK regulator to expand treatment options for advanced-stage patients.

Market | 04/04/2026 | By News Bureau |  150

Lupin Expands Specialty Care Business with VISUfarma Buyout

Lupin Limited has announced the completion of its acquisition of VISUfarma B.V. from GHO Capital Partners LLP, marking a significant step in strengthening its specialty care portfolio and expanding its footprint in Europe.

Market | 02/04/2026 | By Darshana